Tirzepatide 50mg × 10 vials

Description

Tirzepatide 50mg × 10 Vials | Dual GIP and GLP-1 Receptor Agonist Peptide

Tirzepatide 50mg × 10 vials is a revolutionary peptide known for its dual agonist activity on both GIP (Glucose-Dependent Insulinotropic Polypeptide) and GLP-1 (Glucagon-Like Peptide-1) receptors. This unique dual mechanism provides new insights into glucose metabolism, insulin regulation, and body weight management, making Tirzepatide one of the most studied peptides in metabolic and diabetes research.

Each vial contains 50mg of high-purity Tirzepatide, and the pack includes 10 vials, ensuring sufficient quantity for extensive laboratory or preclinical research.

Key Product Specifications

• Product Name: Tirzepatide

• Purity: >98% (HPLC Verified)

• Form: Lyophilized (Freeze-Dried) Peptide Powder

• Strength: 50mg per vial

• Quantity: 10 vials per pack

• Storage: 2–8°C (Refrigerated)

• Molecular Formula: C225H348N48O68

• Molecular Weight: 4813.5 g/mol

Mechanism of Action

Tirzepatide’s dual receptor agonism offers a synergistic effect on metabolic processes:

• GIP Receptor Activation: Improves lipid metabolism and insulin sensitivity.

• GLP-1 Receptor Activation: Increases insulin release, suppresses glucagon production, and promotes satiety.

Together, these mechanisms lead to improved energy regulation, glucose balance, and body composition, making Tirzepatide a valuable peptide for endocrine and metabolic research applications.

Potential Research Applications

• Studies on glucose regulation and insulin dynamics

• Research on obesity and appetite control mechanisms

• Exploration of dual incretin receptor pathways

• Investigation of energy metabolism and fat oxidation

• Preclinical models of type 2 diabetes and metabolic syndrome

For laboratory and scientific research use only. Not for human consumption.

Reconstitution & Storage Guidelines

Reconstitution:

• Reconstitute with bacteriostatic water or sterile water for injection.

• Gently swirl until the peptide fully dissolves. Avoid shaking.

Storage:

• Lyophilized powder: Store at -20°C for long-term stability.

• Reconstituted solution: Keep at 2–8°C and use within research timelines.

• Protect from direct sunlight and avoid repeated freeze–thaw cycles.

Packaging & Quality Assurance

• 10 vials × 50mg Tirzepatide

• Sealed, sterile, high-purity lyophilized powder

• Verified purity through HPLC and Mass Spectrometry

• Packaged in temperature-controlled conditions

• Manufactured under GMP-compliant laboratory standards

Safety and Handling

Tirzepatide is intended strictly for laboratory and scientific research purposes. It is not approved for human or veterinary use. Always handle peptides with care and follow your institution’s safety procedures.

Why Choose Tirzepatide 50mg for Research

• High-purity peptide with verified analytical testing

• Dual incretin receptor activity for advanced metabolic studies

• Reliable stability and consistent formulation

• Packaged for safe, long-term research storage

• Trusted by global research institutions and academic labs

Summary Table

Disclaimer

This compound is not intended for human consumption, medical, or diagnostic purposes. It is supplied only for laboratory research use by qualified professionals under controlled environments.